M&A
N-power firm Exelon Corp to acquire Pepco Holdings for over $5.4 bn
30 Apr 2014
Generating 35,000 megawatts of power that represent approximately 20 per cent of the US nuclear industry’s capacity, Exelon operates the largest number of US nuclear power plants
Bayer offers to swap cash and animal health unit for Merck's consumer healthcare
30 Apr 2014
German healthcare major Bayer AG has offered to swap its animal health unit and also pay some cash in exchange for Merck & Co's consumer healthcare business
Bayer offers to swap cash and animal health unit for Merck's consumer healthcare
30 Apr 2014
German healthcare major Bayer AG has offered to swap its animal health unit and also pay some cash in exchange for Merck & Co's consumer healthcare business
Bayer offers to swap cash and animal health unit for Merck's consumer healthcare
30 Apr 2014
German healthcare major Bayer AG has offered to swap its animal health unit and also pay some cash in exchange for Merck & Co's consumer healthcare business
HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations
30 Apr 2014
The order was in response to a petition for a Sebi inquiry into possible insider trading in Ranbaxy shares that saw heavy trading before the merger with Sun Pharma was announced
HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations
30 Apr 2014
The order was in response to a petition for a Sebi inquiry into possible insider trading in Ranbaxy shares that saw heavy trading before the merger with Sun Pharma was announced
HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations
30 Apr 2014
The order was in response to a petition for a Sebi inquiry into possible insider trading in Ranbaxy shares that saw heavy trading before the merger with Sun Pharma was announced
Siemens to table offer for Alstom if given four weeks to conduct due diligence
30 Apr 2014
On Sunday, Siemens barged into Alstom's late-stage talks to sell its energy assets to General Electric Co (GE) by proposing an asset swap deal worth $14.5 billion
US defence contractors ATK, Orbital Sciences to merge in $5 bn deal
30 Apr 2014
The world's largest ammunition maker, US-based Alliant Techsystems, yesterday said that it will merge its aerospace and defence groups with satellite maker Orbital Sciences Corp
Ophir Energy no longer interested in Premier oil
29 Apr 2014
US audio chips supplier Cirrus Logic to buy British rival Wolfson Microelectronics for $468 mn
29 Apr 2014
Reckitt Benckiser confirms bidding for Merck & Co's consumer health business
29 Apr 2014
British consumer goods company Reckitt Benckiser has emerged as a front runner in the auction, although Bayer AG, Novartis, and Procter & Gamble Co are also in the race
Siemens barges into Alstom - GE deal with asset-swap offer
By By Ravi Kunder | 28 Apr 2014
Siemens proposes to give some of its high-speed train and locomotive businesses plus cash to Alstom in exchange for its power business, which GE was close to buying for $13 billion. By Ravi Kunder
Pfizer confirms AstraZeneca's rejection; to explore options
28 Apr 2014
US drugs giant Pfizer today confirmed that it had made a $98.67 billion (£58.73 billion) takeover offer for AstraZeneca, which was rejected by the UK-based company
Forest Labs to buy GI specialist Furiex in $1.46-bn deal
28 Apr 2014
Forest, which itself is in the process of being acquired by Actavis Plc for $25 billion, said that Actavis supported the deal
Bayer mulls selling plastics unit worth $10.8 bn
28 Apr 2014
With sales of €11.5 billion, Bayer MaterialScience is one of the world’s largest producers of polymers and high-performance plastics.
Wilmar International tables $1.18-bn bid for Australian food firm Goodman Fielder
28 Apr 2014
Australian food company, Goodman Fielder, today rejected an unsolicited $1.18 billion takeover bid from Singapore's agribusiness group Wilmar International Limited, saying the offer undervalued the company.
EID Parry acquires Bayer’s nutraceuticals arm Alimtec in Chlie
26 Apr 2014
Alimtec makes Haematococcus pluvialis biomass, a cultured micro-algae, which is a rich natural source of Astaxanthin for human use
EID Parry acquires Bayer’s nutraceuticals arm Alimtec in Chlie
26 Apr 2014
Alimtec makes Haematococcus pluvialis biomass, a cultured micro-algae, which is a rich natural source of Astaxanthin for human use
Latest articles
Featured articles
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.



